Abraham Ceesay serves as Executive at Cerevel Therapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Abraham Ceesay has executed 31 insider transactions totaling $6.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 17, 2025 involved selling 2,147 shares valued at $61.9K.
Abraham Ceesay currently holds 33,831 shares of Cerevel Therapeutics Holdings, Inc. (CERE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Abraham Ceesay has been a net seller of CERE stock. They have purchased $0 and sold $6.2M worth of shares.
Abraham Ceesay's most recent insider trade was on Dec 17, 2025, when they sold 2,147 shares at $28.84 per share.
Get notified when new Form 4 filings are submitted
| $31.04 |
| Discretionary |
| Dec 17, 2025 | RAPP | $70.4K | Sale | 2,441 | $28.84 | Discretionary |
| Dec 17, 2025 | RAPP | $72.7K | Sale | 2,421 | $30.04 | Discretionary |
| Dec 17, 2025 | RAPP | $16.0K | Sale | 515 | $31.04 | Discretionary |
| Dec 17, 2025 | RAPP | $83.9K | Sale | 2,792 | $30.04 | Discretionary |
| Nov 17, 2025 | RAPP | $72.3K | Sale | 2,841 | $25.44 | Discretionary |
| Nov 17, 2025 | RAPP | $69.2K | Sale | 2,777 | $24.92 | Discretionary |
| Nov 17, 2025 | RAPP | $77.7K | Sale | 3,056 | $25.43 | Discretionary |
| Nov 17, 2025 | RAPP | $55.8K | Sale | 2,242 | $24.91 | Discretionary |
| Oct 15, 2025 | RAPP | $19.8K | Sale | 755 | $26.17 | Discretionary |
| Oct 15, 2025 | RAPP | $111.4K | Sale | 4,328 | $25.75 | Discretionary |
| Oct 15, 2025 | RAPP | $119.5K | Sale | 4,647 | $25.72 | Discretionary |
| Oct 15, 2025 | RAPP | $31.0K | Sale | 1,186 | $26.14 | Discretionary |
| Sep 17, 2025 | RAPP | $18.9K | Sale | 700 | $27.04 | Discretionary |
| Sep 17, 2025 | RAPP | $917.5K | Sale | 34,885 | $26.30 | Discretionary |
| Sep 17, 2025 | RAPP | $37.6K | Sale | 1,400 | $26.87 | Discretionary |
| Sep 17, 2025 | RAPP | $1.0M | Sale | 39,435 | $26.30 | Discretionary |
| Sep 4, 2025 | PCRX | $64.0K | Sale | 2,354 | $27.19 | Discretionary |
| Jun 12, 2024 | PCRX | $0 | Award | 5,230 | $N/A | Discretionary |
| Sep 8, 2022 | CERE | $253.0K | Option Exercise | 19,210 | $13.17 | Discretionary |
| Sep 8, 2022 | CERE | $624.3K | Sale | 19,210 | $32.50 | Discretionary |
| Aug 22, 2022 | CERE | $126.5K | Option Exercise | 9,605 | $13.17 | Discretionary |
| Aug 22, 2022 | CERE | $312.2K | Sale | 9,605 | $32.50 | Discretionary |
| Aug 15, 2022 | CERE | $126.5K | Option Exercise | 9,606 | $13.17 | Discretionary |
| Aug 15, 2022 | CERE | $327.8K | Sale | 9,606 | $34.12 | Discretionary |
| Aug 8, 2022 | CERE | $379.4K | Sale | 9,605 | $39.50 | Discretionary |
| Aug 8, 2022 | CERE | $253.0K | Option Exercise | 19,211 | $13.17 | Discretionary |
| Aug 8, 2022 | CERE | $362.6K | Sale | 9,606 | $37.75 | Discretionary |
| Aug 5, 2022 | CERE | $506.0K | Option Exercise | 38,424 | $13.17 | Discretionary |